|
ADHD, (Last ADHD visit >6 months),
Overdue for follow-up
Clinician Summary
Recommendation 5 of the AAP treatment guidelines suggests once
the child is stable, an office visit every 3 to 6 months allows for
assessment of learning and behavior. These visits also allow assessment of
potential side effects of stimulants, such as decreased appetite and
alteration of weight, height, and growth velocity.
This reminder prompts clinicians to follow up with individuals who have the
following recorded indicators within the electronic health record (EHR)
system:
- Age ≥ 6 yrs and ≤ 18yrs; and
- (ADHD or ADD
on problem list) or med list includes methylphenidate or
dextroamphetamine or mixed-salt amphetamine or atomoxetine; and
- last ADHD
symptom review note written >6 months ago
References
- Clinical
practice guideline: treatment of the school-aged child with
attention-deficit/hyperactivity disorder. Pediatrics. 2001 Oct; 108(4):
1033-44.
- Clinical
practice guideline: diagnosis and evaluation of the child with
attention-deficit/hyperactivity disorder. American Academy
of Pediatrics. Pediatrics. 2000 May; 105(5): 1158-70. Review.
Web
Links
1. American
Academy of Pediatrics http://www.aap.org/policy/s0120.html
2.
NICHQ
ADHD toolkit
http://www.nichq.org/resources/toolkit/
Implementation
Notes
|
Rule
category
|
ADHD
|
|
Rule
title
|
ADHD, Overdue for follow-up
|
|
Primary
Clinical Area
|
Pediatrics
|
|
Secondary
Clinical Area
|
|
|
Risk
Group Definition
|
age ≥ 6 yrs and ≤18 yrs and (ADHD or
ADD on problem list) or
med list includes methylphenidate or dextroamphetamine or mixed-salt
amphetamine or atomoxetine
|
|
Details
for Risk Group
|
Attention
Deficit Disorder problem
Attention Deficit Disorder w/hyperactivity
Attention Deficit Disorder, Childhood
Ritalin La (Methylphenidate Extended Release), Ritalin Sr
(Methylphenidate Sustained release), Ritalin Tablet (Methylphenidate Hcl
Tablet), Metadate ER, Metadate CD, Methylin Oral Liquid, Methylin Chewable,
Concerta, Dexedrine, Dexedrine spansule,
Dextrostat, Adderall, Adderall-XR, atomoxetine
|
|
Triggering
Condition
|
Last ADHD symptom review
note written >6 months ago
|
|
Details
for Triggering
|
Symptom check defined by
use of ADHD templates
|
|
Condition
|
|
|
Displayed
Message
|
Patient
has ADHD: medication/symptom follow-up recommended every 3-6months
|
|
Coded
Responses
|
Snooze
Periods
|
|
A: Symptom review
done today
B: Appointment
scheduled
C: Patient refused
D: Symptom review documented elsewhere
E: Deferred
F: Other
G:
H:
|
A': 6 months
B': 6 months
C': 3 months
D': 6 months
E': 3 months
F': 1 month
G':
H':
|
Disclaimer
These rules
and/or reminders were created using national, state and local guidelines, and
group consensus regarding best practices. These guidelines, and their
interpretation by clinicians at Partners Healthcare System, may not represent
the standard of care across all regions or settings, and are not intended to
be adopted or applied without independent assessment of their suitability for
a particular setting. Moreover, guidelines change over time (for example, the
age range for children who should receive influenza vaccinations was recently
extended to 59 months). The rules and/or reminders may need the addition or
modification of certain items to ensure that they remain consistent with
current guidelines. Therefore, the rules and/or reminders included here are
intended only as examples or guides for the development of similar rules
and/or reminders in other settings. Partners Healthcare System and its
affiliates disclaim any and all responsibility or liability associated with
the use of the rules and/or reminders displayed here by third parties.
|